Synthesis of novel fluorescent probes for the molecular chaperone Hsp90
Authors:
- Sara J FeltsSFSara J Felts
- Henri HuezoHHHenri Huezo
- Neal RosenNRNeal Rosen
- Gabriela ChiosisGCGabriela Chiosis
- 1 November 2003
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (22) , 3975-3978
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Filter binding assay for the geldanamycin–heat shock protein 90 interactionAnalytical Biochemistry, 2003
- HSP90 as a new therapeutic target for cancer therapy: the story unfoldsExpert Opinion on Biological Therapy, 2002
- Coordinated ATP Hydrolysis by the Hsp90 DimerJournal of Biological Chemistry, 2001
- Sensitivity of Mature ErbB2 to Geldanamycin Is Conferred by Its Kinase Domain and Is Mediated by the Chaperone Protein Hsp90Journal of Biological Chemistry, 2001
- C-terminal regions of Hsp90 are important for trapping the nucleotide during the ATPase cycle 1 1Edited by R. HuberJournal of Molecular Biology, 2000
- Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and GeldanamycinJournal of Medicinal Chemistry, 1999
- The Hsp90 complex—a super-chaperone machine as a novel drug targetBiochemical Pharmacology, 1998
- The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycinCancer Chemotherapy and Pharmacology, 1998
- erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationshipsJournal of Medicinal Chemistry, 1995
- Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivativesJournal of Medicinal Chemistry, 1995